Reuters logo
7 months ago
BRIEF-Eisai and Arena Pharmaceuticals says regulatory approval of Belviq in Brazil
December 19, 2016 / 6:38 PM / 7 months ago

BRIEF-Eisai and Arena Pharmaceuticals says regulatory approval of Belviq in Brazil

1 Min Read

Dec 19 (Reuters) - Eisai Co Ltd

* Eisai and Arena Pharmaceuticals announce regulatory approval of BELVIQ (Lorcaserin HCL) in Brazil

* Arena Pharmaceuticals Inc says Belviq is expected to become available following review by Brazil's Medicines Market Regulation Board (CMED) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below